aztreonam inhaled
Selected indexed studies
- Inhaled aztreonam lysine: an evidence-based review. (Expert Opin Pharmacother, 2013) [PMID:23992352]
- Inhaled aztreonam lysine for cystic fibrosis pulmonary disease-related outcomes. (Ann Pharmacother, 2012) [PMID:22764322]
- Inhaled aztreonam. (Nat Rev Drug Discov, 2010) [PMID:20431562]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Inhaled aztreonam lysine: an evidence-based review. (2013) pubmed
- Inhaled aztreonam lysine for cystic fibrosis pulmonary disease-related outcomes. (2012) pubmed
- Inhaled aztreonam. (2010) pubmed
- Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review. (2015) pubmed
- Safety and Tolerability of Inhaled Aztreonam in Children and Adolescents: A Systematic Review and Meta-Analysis. (2025) pubmed
- Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation. (2015) pubmed
- Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies. (2020) pubmed
- Inhaled antibiotics. (2004) pubmed
- Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores. (2015) pubmed
- Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing. (2024) pubmed